<DOC>
	<DOCNO>NCT02709330</DOCNO>
	<brief_summary>This 12-month , widely inclusive , largely virtual , single-center , open-label pilot trial utilizing historical control group . Participants receive Lunasin regimen ask register account PatientsLikeMe website , initial in-clinic visit , ask enter specific data .</brief_summary>
	<brief_title>ALS Reversals - Lunasin Regimen</brief_title>
	<detailed_description>The primary hypothesis supplement regimen contain Lunasin ( refer Lunasin regimen ) decrease rate ALSFRS-S progression 50 % relative match historic control . ALS devastate motor neuron disease cause rapidly progressive muscle weakness , disability premature death . In spite large number attempt ALS trial , significant disease-modifying therapy condition . It recently report patient validated diagnosis ALS , experience dramatic objective improvement speech , swallow limb strength take supplement regimen contain Lunasin . Several patient ALS also report improvement Lunasin regiment , though record obtainable validate . The Lunasin regimen consist : - LunaRich X Capsules - Reliv NOW - mixture 'vitamins , mineral super-powered antioxidant ' - Pro-Vantage - mixture 'soy protein , medium chain triglyceride , creatine , CoQ10 supercharge amino acid ' Dosages titrate target first 6 day . The subject take high tolerate dose remainder 12-month study . There 3 in-clinic visit occur screening/baseline , Month 1 Month 12 . For Months 2-11 , participant make `` virtual visit '' measure ALSFRS-R score weight record PatientsLikeMe website . They also self-report perceived efficacy , compliance , adverse event change concomitant medication .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Male female , age least 18 year . Sporadic familial ALS diagnose possible , laboratorysupported probable , probable , definite define revise El Escorial criterion . Patient able understand express inform consent ( opinion site investigator ) . Patient access Internet desktop computer , laptop , tablet work email address . Patient caregiver willing able use computer enter data secure website . Patient able read write English . Women must able become pregnant ( e.g. , postmenopausal , surgically sterile , use adequate birth control method ) duration study three month study completion . Adequate contraception include : abstinence , hormonal contraception ( oral contraception , implanted contraception , inject contraception hormonal contraception , example patch contraceptive ring ) , intrauterine device ( IUD ) place â‰¥ 3 month , barrier method conjunction spermicide , another adequate method . Patient take experimental treatment ALS . Prior side effect Lunasin . Known soy allergy . Patient medical psychiatric illness could investigator 's opinion interfere patient 's ability participate study . Pregnant woman woman currently breastfeed .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>